Postnatal deficits in brain-derived neurotrophic factor (BDNF) are thought to contribute to pathogenesis of Rett syndrome (RTT), a progressive neurodevelopmental disorder caused by mutations in the gene encoding methyl-CpG-binding protein 2 (MeCP2). In Mecp2-null mice, a model of RTT, BDNF deficits are most pronounced in structures important for autonomic and respiratory control, functions that are severely affected in RTT patients. However, relatively little is known about how these deficits affect neuronal function or how they may be linked to specific RTT endophenotypes. To approach these issues, we analyzed synaptic function in the brainstem nucleus tractus solitarius (nTS), the principal site for integration of primary visceral afferent inputs to central autonomic pathways and a region in which we found markedly reduced levels of BDNF in Mecp2 mutants. Our results demonstrate that the amplitude of spontaneous miniature and evoked EPSCs in nTS neurons is significantly increased in Mecp2-null mice and, accordingly, that mutant cells are more likely than wildtype cells to fire action potentials in response to primary afferent stimulation. These changes occur without any increase in intrinsic neuronal excitability and are unaffected by blockade of inhibitory GABA currents. However, this synaptopathy is associated with decreased BDNF availability in the primary afferent pathway and can be rescued by application of exogenous BDNF. On the basis of these findings, we hypothesize that altered sensory gating in nTS contributes to cardiorespiratory instability in RTT and that nTS is a site at which restoration of normal BDNF signaling could help reestablish normal homeostatic controls.
Introduction
Loss-of-function mutations in the gene encoding methyl-CpGbinding protein 2 (MeCP2) cause most cases of Rett syndrome (RTT), a severe autism spectrum disorder characterized by cognitive, motor, and behavioral deficits as well as marked respiratory arrhythmia and cardiac and gastrointestinal dysautonomia (Chahrour and Zoghbi, 2007) . MeCP2 is a transcriptional regulatory protein, and in its absence, large numbers of genes exhibit abnormal increases or decreases in expression. Therefore, a major challenge in understanding the molecular pathogenesis of RTT has been to link dysregulation of specific gene targets of MeCP2 to particular pathophysiological outcomes.
One consequence of MeCP2 loss in mouse models and RTT patients is reduced expression of brain-derived neurotrophic factor (BDNF) after birth (Chang et al., 2006; Wang et al., 2006; Deng et al., 2007) . In Mecp2-null mice, the earliest and most dramatic BDNF deficits occur in structures critical for respiratory and autonomic control, including the cranial sensory nodose ganglion and brainstem (Wang et al., 2006) . In view of the fact that BDNF normally regulates synaptic function in brainstem respiratory and autonomic cell groups, including the nucleus tractus solitarius [nTS; the principal target of peripheral sensory neurons that convey visceral afferent input to central autonomic pathways ], preBötzinger complex (Thoby-Brisson et al., 2003) , and Kölliker-Fuse nucleus (Kron et al., 2007a (Kron et al., ,b, 2008 , we have hypothesized that reduction of BDNF availability contributes to the disruption of autonomic homeostasis in Mecp2-null mice and, possibly, RTT patients (Ogier and Katz, 2008; Katz et al., 2009 ). This hypothesis is supported by findings from our laboratory that treatment of Mecp2-null mice with the ampakine CX546 increases BDNF expression and improves RTT-like respiratory deficits (Ogier et al., 2007) .
To further define how BDNF deficits associated with loss of MeCP2 may affect respiratory and autonomic network function, the present study first compared the distribution of BDNF protein in the medulla from wild-type and Mecp2-null mice. We then focused on nTS, one of the medullary cell groups exhibiting the largest decline in BDNF levels in the mutants, as a model to examine the effect of reduced BDNF availability on synaptic transmission in Mecp2-null mice. Previous studies in our laboratory showed that BDNF can modulate postsynaptic responses of nTS relay neurons to glutamate by inhibiting postsynaptic AMPA receptors . Therefore, we hypothesized that nTS neurons in Mecp2-null mice would exhibit exaggerated responses to primary afferent stimulation due to loss of this BDNFdependent modulation. The present study demonstrates that nTS relay neurons in Mecp2-null mice exhibit significantly larger EPSCs, and are more likely to fire action potentials in response to afferent stimulation, than in wild-type controls. Normal synaptic responses are restored, however, in Mecp2-null slices treated with exogenous BDNF. We propose, therefore, that the loss of BDNF-dependent modulation at primary afferent synapses in nTS may be a critical factor in dysregulation of autonomic homeostasis in Mecp2 mutant mice and, by implication, RTT patients.
Materials and Methods

Animals. Mecp2
tm1-1Jae mice (Chen et al., 2001) , developed by Dr. R. Jaenisch (Whitehead Institute, Massachusetts Institute of Technology, Cambridge, MA) and obtained from the Mutant Mouse Regional Resource Center (University of California, Davis, Davis, CA), were maintained on a mixed background (sv129, BALB/c, C57BL/6). Male Mecp2 nulls (Mecp2 Ϫ/y ) were generated by crossing heterozygous Mecp2 knock-out females with Mecp2 tm1-1Jae wild-type males (Mecp2 ϩ/y ). All experimental procedures were approved by the Institutional Animal Care and Use Committee at Case Western Reserve University and University of Missouri.
Dye labeling. We used a modification of the technique previously described (Mendelowitz et al., 1992; Kline et al., 2002) to label presynaptic boutons on second-order nTS neurons. Briefly, wild-type adult mice were anesthetized with isoflurane. The vagus nerve was exposed in the neck by a ventral midline excision and isolated from surrounding tissues with Parafilm "M" (Fisher Scientific). Small crystals of the anterograde tracer 4-(4-(didecylamino)styryl)-N-methyl-pyridinium iodide (DiA) (4-Di-10-ASP; Invitrogen) were placed on the isolated intact nerve at the level of the carotid bifurcation and caudal to the nodose ganglion. To prevent dye leakage to surrounding tissues, the region was isolated with a fast hardening silicone elastomer (Kwik-Sil; World Precision Instruments). The animals were then sutured and allowed to recover for a minimum of 3 d. Animals were killed using CO 2 , then transcardially perfused with PLP fixative (0.075 M L-lysine-monohydrochloride, 0.01 M sodium metaperiodate in 0.1 M sodium phosphate buffer; pH ϳ7.4). Brains were removed from the skull, postfixed in PLP fixative for 2 h, and then sectioned with a vibratome (Leica). Forty-five-micrometer sections were processed free-floating for TrkB immunohistochemistry, as described below.
Immunohistochemistry. In situ detection of BDNF protein was performed on brain tissues collected from three sets of Mecp2 wild-type and null littermate pairs. Mice were perfused transcardially with a 4% paraformaldehyde solution prepared in 0.1 M phosphate buffer, pH 7.4. Brains were removed from the skulls, postfixed, cryoprotected in sucrose, frozen in isopentane, and stored at Ϫ80°C. Cryostat-cut sections (25 m, coronal) were processed free-floating for BDNF immunostaining, using a rabbit polyclonal anti-BDNF antibody (1:1000; Amgen), a biotinylated goat anti-rabbit IgG antibody (1:400; Vector), peroxidaseconjugated avidin-biotin complex (1:150; Vector), and diaminobenzidine (Sigma). In a subset of tissue, sections were incubated with rabbit polyclonal anti-TH (1:200; Pel-Freeze) and visualized using FITC-goat anti-rabbit IgG (ICN/Cappel).
Free-floating sections were also processed for BDNF and TrkB double immunodetection, using a mouse monoclonal anti-BDNF antibody (mAb 9, a generous gift from Prof. Yves-Alain Barde, University of Basel, Basel Switzerland) (Kolbeck et al., 1999) and a chicken polyclonal antiTrkB antibody (1:100, Promega). An Alexa Fluor 488-conjugated donkey anti-mouse antibody was used for BDNF immunodetection. A biotinyltyramide amplification step (PerkinElmer) and were used for TrkB immunodetection. Sections were imaged with a laser scanning confocal microscope (Leica TCS SP2 MP, Leica Microsystems) using a 40ϫ oil-immersion objective.
Nissl staining protocol. Tissue processing was similar to as described above. Twenty-five-micrometer-thick cryostat-cut sections were collected in PBS then mounted onto SuperFrost Plus slides and allowed to dry. Sections were incubated in a 0.5% Cresyl Violet acetate solution for 5 min, quickly rinsed in distilled water then dehydrated in graded ethanol solutions (50, 75, 95, and 100%) . Sections were cleared in CitriSolv (Fisher) and mounted under coverslip using Permount (Fisher).
Brainstem slice preparation and electrophysiology. Brainstem slices containing the nTS were prepared from P35-P48 d mice as previously described (Kline et al., 2005) . Mice were anesthetized with isoflurane and decapitated. The brainstem was removed and placed in ice-cold lowcalcium, high-magnesium artificial CSF (aCSF) containing the following (in mM): 124 NaCl, 3 KCl, 1.2 NaH 2 PO 4 , 1.2 MgSO 4 , 2 MgCl 2 , 25 NaHCO 3 , 11 D-glucose, 0.4 L-ascorbic acid, and 1 CaCl 2 , saturated with 95% O 2 -5% CO 2 , pH 7.4, 300 mOsm. Horizontal slices (ϳ220 m) were cut with a stainless steel blade (Campden Instruments) using a vibrating microtome (Leica VT 1000S). Tissue sections were placed in a superfusion chamber (RC-26G, Warner Instruments, volume, ϳ234 l) that contained inlet and outlet ports for aCSF flow. The submerged sections were secured with a nylon mesh and superfused at a flow rate of 3 ml/min with normal recording aCSF at 31-33°C. Recording aCSF contained the following (in mM): 125 NaCl, 3 KCl, 1.2 NaH 2 PO 4 , 1.2 MgSO 4 , 0.4 L-ascorbic acid, 25 NaHCO 3 , 10 D-glucose, and 2 CaCl 2 , saturated with 95% O 2 -5% CO 2 , pH 7.4, 300 mOsm. All of the recordings were made from cells in the medial nTS. Neurons in the nTS were visualized using an Olympus microscope (BX51WI, 40ϫ magnification) equipped with differential interface contrast and an infrared-sensitive camera. The pipette was guided using a piezoelectric micromanipulator (PCS-6000; Burleigh). Recording electrodes (8250 glass; 3.5-5.0 M⍀) were filled with a solution containing the following (in mM): 10 NaCl, 130 K ϩ gluconate, 11 EGTA, 1 CaCl 2 , 10 HEPES, 1 MgCl 2 , 2 MgATP, and 0.2 NaGTP, pH 7.3, 295-300 mOsm. Evoked EPSCs and action potentials were generated by placing a concentric bipolar stimulating electrode (Frederick Haer) on tractus solitarius (TS) containing visceral afferents (Andresen and Kunze, 1994; Kline, 2008) and stimulating (0.1 ms duration) at frequencies of 0.5 and 20 Hz with an isolated programmable stimulator (AMPI). In experiments in which we wished to record spontaneous miniature EPSCs (mEPSCs), the extracellular solution contained 1.0 M tetrodotoxin (TTX) and 10 M bicuculline methobromide. In all of the voltage-clamp protocols, neurons were voltage clamped at Ϫ60 mV in the whole-cell configuration. Data were filtered at 2 kHz and sampled at 10 kHz using pClamp10 software (Molecular Devices). Neurons were rejected if resting membrane was more positive than Ϫ45 mV upon initial whole-cell access or if access resistance was not stable throughout recording.
Electrophysiological data were analyzed with Molecular Devices Clampfit, Microsoft Excel, and SigmaPlot software. Each data point for a given trial was an average of 5-20 current sweeps. Synaptic events were compared between control and null mice using an unpaired t test or two-way repeated measures ANOVA (RM ANOVA). Spontaneous miniature EPSC distributions were compared using Kolmogorov-Smirnov tests. p values Ͻ0.05 were considered significant. Data were presented as the mean Ϯ SEM.
Results
BDNF protein distribution in the medulla of P35 wild-type mice
To define potential sites at which dysregulation of BDNF expression may influence autonomic and respiratory control, we first compared the brainstem distribution of BDNF protein in P35 wild-type (Mecp2 ϩ/y ) and Mecp2-null (Mecp2 Ϫ/y ) mice. We chose P35 mice because this is an age at which respiratory function is severely disrupted in Mecp2-null animals (Ogier et al., 2007) . In wild-type mice, BDNF protein is detectable in neuronal perikarya and varicose neuronal processes located in diverse cell groups of the medulla oblongata, including cranial sensory and motor nuclei, the medullary reticular formation, the nTS, and the area postrema, a circumventricular organ located in the caudal dorsomedial medulla ( Table  1 ). The highest density of BDNF-positive cell bodies is found in the spinal trigeminal nucleus (pars caudalis and interpolaris) and area postrema, whereas scattered cells are observed in the inferior olive, nTS, prepositus nucleus, and the dorsomedial part of the spinal trigeminal nucleus. BDNF-positive neuronal processes are found at high density in the inferior olive, nTS, dorsal motor nucleus of the vagus nerve, and the dorsomedial part of the principal sensory nucleus of the trigeminal nerve (Table 1) . Lower densities of BDNF-stained processes are observed in the medullary reticular formation, gracile nucleus, spinal trigeminal tract and nucleus (pars caudalis and interpolaris), motor nucleus of the glossopharyngeal nerve, area postrema, A1/C1, nucleus ambiguus, ventral spinocerebellar tract, prepositus nucleus, raphe nuclei (obscurus and magnus parts), and lateral paragigantocellularis nucleus.
Regionally selective deficits in BDNF in P35 Mecp2-null mice Mecp2-null mice exhibit regionally selective deficits in the intensity of BDNF staining in perikarya and fibers at P35 (Table 1) . Dramatic reductions in BDNF fiber staining are observed in autonomic and respiratory-related cell groups, including the dorsal motor nucleus of the vagus nerve ( Fig. 1 A1,A2,A3) , nTS ( Fig.  1 A1,A2,A3 ), area postrema ( Fig. 1 A1,A2,A3 ), nucleus ambiguus (Fig. 1B1,B2,B3 ), and medullary reticular nuclei (Fig. 1B1,B2,B3 ). All other regions exhibit moderate [for example, A1/C1 (Fig.  1C1 ,C2,C3)] to marginal reductions in the density of BDNF-positive fibers and cell bodies compared to controls.
Abnormal synaptic function in Mecp2-null mice
To determine whether or not reduced BDNF expression is associated with altered synaptic function, we compared synaptic responses of nTS relay neurons in wild-type and Mecp2-null mice. Although nTS is only one of several brainstem cell groups showing a dramatic reduction in BDNF protein in Mecp2-null mice, it is perhaps the best studied in terms of BDNF responsiveness in normal animals [see Katz (2005) and references therein]. In particular, BDNF can strongly modulate glutamatergic activation of second-order nTS neurons by inhibiting postsynaptic AMPA receptors . Thus, we hypothesized that nTS second-order neurons in Mecp2-null mice would exhibit abnormally large responses to primary afferent stimulation due to reduced BDNF-dependent modulation.
To define synaptic function in the nTS, we used horizontal brainstem slice preparations from P35-P48 wild-type and Mecp2-null mice to compare EPSCs evoked by stimulation of fibers in the TS, the principal pathway for primary afferent inputs to nTS. We focused in particular on neurons in the medial subnucleus (mnTS), which express TrkB and are densely innervated by BDNF-positive fibers in wild-type animals (Fig. 2) , and constitute a critical synaptic site for cardiorespiratory control (Andresen and Kunze, 1994; Subramanian et al., 2007) . Only cells receiving monosynaptic input, defined by an SD of EPSC latency (jitter) of Ͻ250 s, were considered for analysis (Doyle and Andresen, 2001; Kline et al., 2002) .
TS stimulation at 0.5 Hz evoked monosynaptic EPSCs (TSEPSCs) at constant latency in both wild-type and mutant animals (Fig. 3A) . However, TS-EPSC amplitude was significantly greater in Mecp2
Ϫ/y mice than in wild-type controls [wt, 82.3 Ϯ 6.9 pA (n ϭ 18) vs null, 135.8 Ϯ 11.4 pA (n ϭ 13), p Ͻ 0.05; t test]. We next asked whether increasing the frequency of TS stimulation would significantly alter afferent processing in wild-type versus null nTS cells. As is characteristic of nTS neurons (Miles, 1986) , TS stimulation at 20 Hz for 10 episodes produced TS-EPSC depression following the first evoked event in both groups of mice (Fig. 3B) . Although the magnitude of synaptic depression was comparable between Mecp2 Ϫ/y and Mecp2 ϩ/y mice ( p Ͼ 0.05), the absolute amplitude of TS-EPSCs was increased in Mecp2 73.9 Ϯ 6.1 pA in mutants ( p Ͻ 0.05, t test). The first TS-EPSC averaged 101.6 Ϯ 12.1 pA (n ϭ 22) in wild-type mice and 156.3 Ϯ 15.6 pA (n ϭ 26) in null mice, and EPSC amplitude remained elevated in the mutants throughout the stimulus train ( p Ͻ 0.05, two-way repeated-measures ANOVA) (Fig. 3C ).
nTS neurons from Mecp2
؊/y mice exhibit enhanced probability of action potential firing To examine whether elevated synaptic current amplitude in Mecp2 Ϫ/y mice is associated with enhanced spiking, we compared the probability of action potential generation in response to TS stimulation in wild-type and null nTS cells. Although TS stimulation at 20 Hz elicited EPSPs in both groups of mice, Mecp2 Ϫ/y cells were four times more likely to generate an action potential than wild-type controls. Specifically, TS stimulation at resting potential elicited action potential generation in 8 of 10 null cells during the train, but only in 2 of 10 wild-type cells ( p Ͻ 0.05, z test). This is despite the fact that the resting membrane potential was comparable between the two groups (null, Ϫ54 Ϯ 1 mV, n ϭ 10 vs wild type, Ϫ57 Ϯ 2 mV, n ϭ 10 each, p Ͼ 0.05, t test). ϩ/y were examined by currentinduced step depolarization. In monosynaptic cells, current injection (ϩ10 -70 pA steps, 500 ms, interval of 2 s) from a constant holding potential of Ϫ60 mV evoked action potential discharge in all cells studied. The number of action potentials, as well as the likelihood of generating an action potential, in a given current step was comparable between the two groups ( p Ͼ 0.05, data not shown). Likewise, the amplitude, afterhyperpolarization, half-width, and threshold, as well as rise time and slope, of the first current-evoked action potential were comparable between both groups (Table 2) . Action potential decay time and slope were significantly faster in null mice.
Intrinsic excitability of nTS neurons is comparable in
Enhanced EPSCs in Mecp2
؊/y mice are not due to inhibitory shunting To examine the potential contribution of inhibitory shunting to the EPSC phenotype of Mecp2 10 events; control, 59.2 Ϯ 7.0 vs bicuculline, 53.4 Ϯ 7.1 pA) (Fig. 4 A, B) ( p Ͼ 0.05). These data suggest that reduced inhibitory shunting did not occur in either group and is not responsible for elevated EPSC amplitude in null mice.
Enhanced miniature EPSCs in
Mecp2-null mice mEPSCs represent the random, action potential-independent release of neurotransmitter and provide information about possible changes in the presynaptic release process. To determine whether mEPSCs were altered by loss of MeCP2, we compared the amplitude and frequency of mEPSCs recorded in the presence of the Na ϩ channel blocker TTX (1 M) and bicuculline (10 M) in wild-type and null mice. Examples of spontaneous miniature activity in a wild-type and null mouse are shown in Figure 5A . Plotting the cumulative probability plots for mEPSC amplitudes demonstrated a significant rightward shift in null mice, indicating an increase in amplitude ( p Ͻ 0.05; Kolmogorov-Smirnov test) (Fig. 5B ) (n ϭ 10 cells each). Similarly, cumulative interevent intervals of mEPSCs demonstrated a significant leftward shift in null mice, indicating an increase in frequency of miniature events ( p Ͻ 0.05; Kolmogorov-Smirnov test) (Fig. 5C ).
Exogenous BDNF rescues abnormal EPSC amplitude in Mecp2
؊/y mice In view of our previous finding that BDNF can modulate glutamatergic excitation of second-order nTS neurons , as well as the fact that BDNF is severely depleted in nTS in Mecp2-null mice (present study), we examined whether or not exogenous BDNF could rescue the mutant synaptic phenotype. As shown in Figure 6 , bath application of BDNF (100 ng/ml, 15 min) decreased the amplitude of TSEPSCs evoked by 0.1 or 20 Hz (Fig. 6 A) stimulation in Mecp2 Ϫ/y mice to wildtype values. At 20 Hz, TS-EPSC amplitude averaged across the entire stimulus train decreased from 87.6 Ϯ 9.7 pA (before BDNF) to 41.9 Ϯ 5.1 pA (after BDNF; p Ͻ 0.05, paired t test, n ϭ 5). This decrease in average amplitude in the presence of BDNF was reflected in smaller TS-EPSCs throughout the duration of the stimulus train (Fig. 6 B) and was partially reversible (Fig. 6C) . Moreover, restoration of wild-type TS-EPSC amplitude in null mice during BDNF treatment was accompanied by a significant reduction in the number of action potentials elicited by TS stimulation (20 Hz) (Fig. 6 D) (control, 20.5 Ϯ 6.7 vs BDNF, 13.1 Ϯ 6.7, paired t test p Ͻ 0.05). This reduction in discharge in the presence of BDNF was not due to alterations in resting membrane potential (control, Ϫ53.2 Ϯ 1.97 vs BDNF, Ϫ54.9 Ϯ 1.7 mV, p Ͼ 0.05, paired t test). Exogenous BDNF also decreased the averaged TS-EPSC amplitude in wild-type mice, albeit to a lesser degree than in mutants (49.8 Ϯ 5.4 pA before BDNF to 41.1 Ϯ 3.7 pA after BDNF; p Ͻ 0.05, paired t test, n ϭ 5). In addition to evoked responses, we also compared the effect of exogenous BDNF on miniature EPSCs, which exhibit increased amplitude and frequency in null mice (Fig. 5) . As shown in Figure 6E , BDNF induced significant shifts in the cumulative distributions curves for mEPSC size and interevent interval, indicating reductions in amplitude and frequency, respectively (p Ͻ 0.05; Kolmogorov-Smirnov test). 
Discussion
RTT patients and Mecp2 mutant mice exhibit profound disturbances of cardiorespiratory homeostasis that appear to arise, at least in part, from dysregulation of modulatory inputs to brainstem pattern generators and reflex pathways (for review, see Katz et al., 2009) . This is illustrated, for example, by the marked state dependence of cardiorespiratory dysfunction in RTT patients (Weese-Mayer et al., 2008) and by recent observations that hypoxic ventilatory reflexes are greatly exaggerated in Mecp2-null mice (Bissonnette and Knopp, 2006; Roux et al., 2008; Voituron et al., 2009) . These findings are consistent with observations in other neural systems that the normal balance between synaptic excitation and inhibition is disrupted by loss of MeCP2 function. For example, Dani et al. (2005) observed reduced activity in cortical slices from Mecp2-null mice resulting from a loss of excitatory synaptic drive with no change in intrinsic electrical excitability. In contrast, Medrihan et al. (2008) observed a reduction in IPSCs in the ventrolateral medulla of Mecp2-null mice resulting from reduced levels of GABA and decreased expression of GABA receptor subunits. In hippocampus, on the other hand, both glutamatergic synapse number (Chao et al., 2007) and the strength of basal inhibitory rhythms are decreased in the absence of MeCP2. However, despite markedly abnormal autonomic and respiratory control in RTT, relatively little is known about synaptic deficits caused by loss of MeCP2 in brainstem autonomic reflex pathways.
The present study demonstrates dysregulation of primary afferent synaptic transmission in nTS, a critical site for reflex modulation of autonomic and respiratory function, in Mecp2-null mice. Specifically, we find that the amplitude of spontaneous miniature and evoked EPSCs recorded from second-order nTS neurons is significantly increased in mutants compared to wild-type controls and, accordingly, that mutant cells are more likely to fire action potentials in response to afferent stimulation. These changes occur with no alteration in resting membrane potential, input resistance, or action potential firing in response to step current injections, indicating that they are not due to an increase in the intrinsic excitability of the postsynaptic cells. Moreover, the difference in EPSC amplitude between wild-type and null mice is unaffected by application of bicuculline, which blocks inhibitory GABAergic signaling. Thus, our data indicate that the synaptic phenotype of Mecp2-null nTS neurons most likely reflects either enhanced excitatory synaptic drive and/or decreased inhibition (non-GABAergic) of postsynaptic responses to primary afferent stimulation.
The amplitude of postsynaptic responses to primary afferent stimulation in nTS is normally regulated by interactions between glutamate, released from afferent terminals, and multiple presynaptic and postsynaptic neuromodulators, including BDNF , dopamine (Kline et al., 2002) , GABA (Chen and Bonham, 2005; Bailey et al., 2008) , and others [for review, see Andresen and Kunze (1994) and Kline (2008) ]. BDNF is synthesized and released by nodose-petrosal cranial sensory ganglion cells (NG), the primary source of peripheral afferent inputs to nTS (Brady et al., 1999; , and is also expressed by scattered neurons within nTS itself (Conner et al., 1997; present study) . Moreover, BDNF can potently modulate or inhibit glutamatergic excitation of isolated second-order nTS relay neurons through activation of postsynaptic TrkB receptors . In Mecp2-null mice, BDNF protein levels fall progressively after birth, reaching ϳ50% wild-type values in the NG and medulla by the fifth postnatal week (Wang et al., 2006) . This BDNF deficit is particularly striking in the neuropil in nTS (Ogier et al., 2007; present study) and is accompanied by a significant reduction in the absolute amount of BDNF released from NG neurons (Wang et al., 2006) . Thus, given the inhibitory role of BDNF at primary afferent synapses in nTS , it seems likely that reduced BDNF availability contributes to the abnormally large synaptic responses we observed in second-order nTS neurons in Mecp2-null mice. However, the fact that mEPSC frequency was slightly increased in mutants compared to controls suggests that enhanced presynaptic glutamate release may also play a role.
The possibility that reduced BDNF availability underlies the mutant synaptic phenotype is further supported by our finding that treatment of nTS slices with exogenous BDNF restores the amplitude of spontaneous and evoked EPSCs to wild-type values and ameliorates the increase in TS-evoked action potential discharge.
Given that TrkB is abundantly expressed by nTS neurons, and virtually undetectable in primary afferent inputs to nTS after birth (Zhuo and Helke, 1996 ; present study), these effects of BDNF are most likely postsynaptic. This possibility is supported by our previous finding that BDNF inhibits postsynaptic AMPA receptors expressed by second-order nTS relay neurons . Moreover, the fact that primary afferent fibers do not express TrkB indicates that the reduction in mEPSC frequency in BDNF-treated mutant slices is most likely an indirect effect mediated by TrkBpositive interneurons.
Regardless of the underlying mechanism(s), these results offer a plausible synaptic mechanism to explain why nTS-mediated reflexes are exaggerated in the absence of MeCP2 (Bissonnette and Knopp, 2006; Roux et al., 2008; Voituron, et al., 2009 ). More generally, increased gain in afferent inputs to cardiorespiratory control networks in the brainstem is thought to have a destabilizing effect on motor output and may therefore contribute to the overall instability in respiratory behavior and cardiovascular regulation that are characteristic of RTT Katz et al., 2009) . In fact, loss of MeCP2 has previously been shown to result in a failure of reflex desensitization to repetitive vagal afferent stimulation in nTS, which, in turn, contributes to highly variable postinspiratory activity and breathing arrhythmia (Stettner et al., 2007) . We believe that reduced BDNF-dependent modulation of glutamatergic transmission in nTS, resulting in exaggerated postsynaptic responses to primary afferent stimulation, as described here, could play a key role in generating these disturbances of reflex sensitization and, thereby, cardiorespiratory arrhythmias in RTT.
In addition to cardiorespiratory instability, RTT patients exhibit a significant increase in mean respiratory frequency that is recapitulated in the strain of Mecp2-null mice used in the present study (Ogier et al., 2007) . We previously showed that ampakine treatment of these mice restores normal respiratory frequency in association with an increase in BDNF protein levels in the nodose ganglion (Ogier et al., 2007) . The present findings suggest that the ability of ampakine treatment to rescue respiratory frequency may be due, at least in part, to restoration of BDNF-dependent modulation at primary afferent synapses in nTS. More generally, the fact that exogenous BDNF reverses the nTS synaptopathy in Mecp2-null mice further supports the possibility that strategies aimed at restoring normal BDNF signaling may be of therapeutic benefit in RTT (Ogier and Katz, 2008; Katz et al., 2009 ).
